 Kaiah Mae Fields
| Title | Post-Doctoral Fellow |
|---|
| Institution | University of Colorado Denver - Anschutz Medical Campus |
|---|
| Department | SOM-PHARM General Operations |
|---|
|
|
|
 Bibliographic
-
Fields KM, Terue Rizzo Kodama G, Danis E, Olivas-Corral JG, Rosenbaum SR, Kantheti U, Sarioglu G, Citarella E, Wick L, Matlin K, Aloe B, Hawkins EG, Wolin AR, LaVeck A, Hughes CJ, Wang X, Zhao R, Tamburini BAJ, Bouchard G, Slansky JE, Ford HL. Genetic and Pharmacologic Targeting of Eya3 in Macrophages Drives Anti-Tumor Immunity in Triple-Negative Breast Cancer. bioRxiv. 2026 Jul 23. PMID: 42539001.
-
Rosenbaum SR, Fields KM, Ford HL. Masters of adaptation: How cancer and immune cell plasticity mediates tumor progression. PLoS Biol. 2025 Jul; 23(7):e3003301. PMID: 40663561.
-
Rosenbaum SR, Hughes CJ, Fields KM, Purdy SC, Gustafson AL, Wolin A, Hampton D, Shrivastava NM, Turner N, Danis E, Ebmeier C, Spoelstra N, Richer J, Jedlicka P, Costello JC, Zhao R, Ford HL. EYA3 regulation of NF-?B and CCL2 suppresses cytotoxic NK cells in the premetastatic niche to promote TNBC metastasis. Sci Adv. 2025 May 09; 11(19):eadt0504. PMID: 40333987.
-
Rosenbaum SR, Hughes CJ, Fields KM, Purdy SC, Gustafson A, Wolin A, Hampton D, Turner N, Ebmeier C, Costello JC, Ford HL. An EYA3/NF-?B/CCL2 signaling axis suppresses cytotoxic NK cells in the pre-metastatic niche to promote triple negative breast cancer metastasis. bioRxiv. 2024 Aug 03. PMID: 39211066.
-
Hughes CJ, Alderman C, Wolin AR, Fields KM, Zhao R, Ford HL. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer. Biochim Biophys Acta Rev Cancer. 2024 05; 1879(3):189098. PMID: 38555001.
-
Hughes CJ, Fields KM, Danis EP, Hsu JY, Neelakantan D, Vincent MY, Gustafson AL, Oliphant MJ, Sreekanth V, Zaberezhnyy V, Costello JC, Jedlicka P, Ford HL. SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing Sarcoma. Nat Commun. 2023 07 19; 14(1):4357. PMID: 37468459.
-
Taslimi A, Fields KM, Dahl KD, Liu Q, Tucker CL. Spatiotemporal control of necroptotic cell death and plasma membrane recruitment using engineered MLKL domains. Cell Death Discov. 2022 Nov 29; 8(1):469. PMID: 36446770.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2022 | 1 | | 2023 | 1 | | 2024 | 2 | | 2025 | 2 | | 2026 | 1 |
To return to the timeline, click here.
|
Fields's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|